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Objective: The aim of this study is to clarify the feasibility and efﬁcacy of fetoscopic laser photocoagu-
lation of placental vascular communicating vessels (FLP) on twinetwin transfusion syndrome (TTTS)
after 26 weeks of gestation.
Materials and Methods: This is a prospective pilot study investigating all cases of TTTS between 26 weeks
and 27 weeks during 2012 and 2013 in Japan. The primary endpoints in this study were the feasibility of
FLP and rate of harmful complications for the mother's health. Also, perinatal prognosis was investigated.
Results: Six cases were enrolled and underwent FLP. Two of the six cases were classiﬁed preoperatively
as Quintero Stage II and four cases were Stage III. FLP was completely achieved in all six cases. No severe
maternal complications were noted during and immediately after the surgery. All but one case continued
the pregnancies > 14 days after FLP. The median gestational age at delivery was 33.4 weeks (28.0e36.6
weeks). All 12 fetuses survived at the 28th day in the neonatal period. No case was diagnosed with ce-
rebral lesion at the neonatal period.
Conclusion: This prospective pilot study shows that FLP could be a therapeutic option for TTTS between
26 weeks and 27 weeks of gestation.
Copyright© 2016, Taiwan Association of Obstetrics& Gynecology. Published by Elsevier Taiwan LLC. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Twin-to-twin transfusion syndrome (TTTS) occurs in ~10% of
monochorionic (MC) twin pregnancies and carries a high risk of
perinatal morbidity andmortality [1,2]. The precise etiology of TTTS
remains uncertain, although unbalanced blood ﬂow between two
fetuses via placental vascular anastomoses, resulting from a net
transfusion of blood ﬂow from the donor twin to the recipient twin,
attributes the pathophysiology of TTTS. If left untreated, perinatalrics and Gynecology, Toho
hi, Ota-ku, Tokyo, 143-8541,
p (M. Nakata).
bstetrics & Gynecology. Publishedmortality rates reach 90% [3]. Fetoscopic laser photocoagulation of
placental vascular communicating vessels (FLP) has been proven as
the best therapeutic option in TTTS with signiﬁcant perinatal out-
comes [4e7].
Most published studies on FLP for TTTS were limited to preg-
nancies treated before 26 weeks of gestation [5e8]. The reason for
this limitation is that fetoscopic procedure itself was initially
considered as a more invasive therapeutic approach than palliative
amnioreduction or elective delivery if gestational age was enough
to gain fetal viability [9]. However, fetoscopic procedure has gained
wide acceptance almost two decades after the ﬁrst publications on
FLP for TTTS [10]. Recently a few investigators have reported the
introduction of FLP for TTTS beyond 26 weeks of gestation [11], but
there is still little evidence to support the feasibility and efﬁcacy of
FLP after 26 weeks of gestation.by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Table 1
Perioperative characteristics of six patients.
Maternal age 30.7 (26e39)
Para 2 (0e4)
ART, n 0
Quintero stage, n
I 0
II 2
III 4
IV 0
No. of gestational wks at FLP 26.9 (26.1e27.6)
MVP in recipient sac (cm) 11.4 (10.2e12.0)
Tocolysis before operation 4 (67)
Operation time (min) 47 (25e72)
Anterior placenta 1 (17)
Volume of amniotic ﬂuid reduction (mL) 2110 (1050e3350)
Data are presented as median (range) or n (%), unless otherwise indicated.
ART¼ assisted reproductive technology; FLP¼ fetoscopic laser photocoagulation of
placental vascular communicating vessels; MVP¼maximum vertical pocket.
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of FLP for TTTS diagnosed after 26 weeks of gestation.
Materials and methods
This is a prospective pilot study, investigating all cases of MC
twinpregnancies complicatedwith TTTS between 26þ 0weeks and
27 þ 6 weeks of gestation, who underwent FLP at three institutions
in Japan from January 2012 to December 2013. The study was
approved by the ethics committee in each institution and patients
provided written informed consent. This clinical study was regis-
tered under Number UMIN000007208 (http://www.umin.ac.jp/).
Gestational agewas calculated by the last menstrual period and
corrected by the ﬁrst trimester ultrasound. Chorionicity was
established at the ﬁrst trimester ultrasound. The diagnostic
criteria of TTTS were deﬁned as polyhydramnios with a maximum
vertical pocket (MVP)  10.0 cm in the recipient fetus and oligo-
hydramnios with an MVP 2.0 cm in the donor fetus according to
the Eurofetus criteria [9]. Preoperative ultrasound evaluations
including fetal biometry, amniotic ﬂuid volume estimation, and
pulsed Doppler examination were performed to stage patients
according to the Quintero staging system [12]. FLP was performed
on the basis of previously described methods [7,13,14]. A 3.5-mm
diagnostic fetoscope and a 3-mm operating fetoscope (Richard
Wolf, Knittlingen, Germany) or a 2-mm fetoscope with a 3-mm
cannula (Karl Storz, Tuttlingen, Germany) were used according
to the physician's predilection. All vascular anastomoses were
interrupted selectively using a Nd:YAG laser. The amniotic ﬂuid
was subsequently drained through the cannula until the MVP
reached < 8 cm. All patients gave written informed consent to
undergo FLP. Perioperative tocolysis as well as prophylactic anti-
biotics were provided. Postoperative care with weekly ultrasound
evaluation, including pulsed Doppler assessment and delivery and
neonatal management was provided by the referring perinatal
centers. Delivery was determined according to obstetrical in-
dications by the attending physician. Neonates were routinely
examined by cerebral ultrasonography. Magnetic resonance im-
aging was performed when clinical examination or ultrasonog-
raphywas suggestive of an abnormality. All infants were examined
by neonatologists at 28 days of age. A color dye injection test of the
placenta was prospectively planned to investigate the presence or
absence of residual vascular anastomoses.
The primary endpoints in this study were the feasibility of FLP
and the rate of harmful complications for the mother's health.
Other measurement outcomes were the rate of surviving twins, the
survival of at least one twin, and the rate of major neurological
complications in survivors at 28 days of age. Major neurological
complications were deﬁned as severe intraventricular hemorrhage
(Grade 3 or 4) and/or cystic periventricular leukomalacia.
Results
Six cases were enrolled and underwent FLP during the study
period. Perioperative characteristics are presented in Table 1.
Four of six cases were classiﬁed as Quintero Stage III, and intra-
venous administration of tocolytic agents such as magnesium
sulfate and/or ritodrine hydrochloride was given in four patients
due to threatened premature labor. FLP was completed for all six
cases without major maternal complications during the surgery.
The median operating time was 47 minutes (range, 25e72
minutes).
Detailed perinatal outcomes are presented in Table 2. No fetal
demise was noted in all six cases. The median gestational age at
delivery was 33.4 weeks (range, 28.0e36.6 weeks). All but one
case delivered > 2 weeks after FLP. One patient delivered 3 daysafter FLP because of tocolysis failure followed by maternal pul-
monary edema. This required intensive care but the patient
improved soon after the delivery (Case 6). Five patients could
continue pregnancy > 2 weeks after the surgery and improve-
ment of polyhydramnios and oligohydramnios in each twin was
conﬁrmed. The incidence of preterm delivery < 32 weeks was
50% (n¼ 3). The number of extremely low birth weight infants
(< 1000 g) was two (17%) of 12 live-born twins. Overall, perinatal
survival at 28 days was 100%. Four twins were complicated
with respiratory distress syndrome (Case 3 and 6). One twin
born with extremely low birth weight suffered with small-
intestine perforation (Case 6). All twins survived without
neurological complications at 28 days of age. Pathological ex-
amination of delivered placenta showed no residual anastomo-
ses in all cases.Discussion
This study shows that FLP for TTTS after 26 weeks of gestation is
feasible and provides a good prognosis compared with standard
therapeutic strategy for TTTS before 26 weeks of gestation [7]. As a
result, all twins survived after FLP.
Recently, several studies on FLP for TTTS after 26 weeks of
gestation have been published in the literature. Middeldorp et al
[11] reported the possibility of FLP instead of amnioreduction in
2007, and then only two reports were published. Valsky et al [15]
reported 28 cases of FLP between 26 þ 0 weeks and 28 þ 6
weeks of gestationwith a 92% rate of at least one survivor and other
reports on 18 cases also showed a 94% rate of at least one survivor
[16]. Our results were similar to these results. In these reports,
gestational age at delivery ranges from 31 weeks to 33 weeks of
gestation, which is compatible with our results.
We were initially concerned with surgical and perinatal com-
plications, but these complications were less than anticipated. In
fact, premature rupture of membrane at less than 32 weeks
occurred in two of six cases, resulting in premature delivery
before 32 weeks, but this was compatible with previous reports.
Unfortunately, one case resulted in early delivery (3 days after
FLP). In this case, more than one tocolytic agent had been
administrated even before FLP, and tocolysis failure was not
considered preventable. Most of our cases were complicated with
premature preterm labor and amnioreduction for the improve-
ment of polyhydramnios was required, in which the median vol-
ume of reduced amniotic ﬂuid was > 2000 mL. This might indicate
that TTTS after 26 weeks could manifest more typical features of
twin polyhydramnioseoligohydramnios sequence than that
Table 2
Perinatal outcome.
Case Quintero
stage
GA at FLP GA at delivery Interval from FLP
to delivery (d)
Reason for delivery Recipient Twin Donor Twin survival (n)
BW (g) complication BW (g) complication
1 3 26.1 36.0 69 PIH 2292 d 2262 d 2
2 3 26.1 36.6 73 planned delivery 2170 d 2580 d 2
3 2 26.7 30.0 23 PROM 1310 RDS 1400 RDS 2
4 3 27.7 30.9 22 PROM 1612 d 1806 d 2
5 3 27.0 36.4 66 tocolysis failure 2154 d 2166 d 2
6 2 27.6 28.0 3 tocolysis failure,
pulmonary edema
822 RDS, small-intestine
perforation
977 RDS 2
BW¼ birth weight; FLP¼ fetoscopic laser photocoagulation of placental vascular communicating vessels; GA¼ gestational age; PIH¼ pregnancy-induced hypertension;
PROM¼ premature rupture of membrane; RDS¼ respiratory distress syndrome.
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such as premature preterm labor.
In this study the criterion of TTTS for FLP was changed from our
previous study, which focused on TTTS between 26 weeks and 27
weeks of gestation [7]. Speciﬁcally, polyhydramnios of the recipient
twin was deﬁned as MVP > 10 cm. The reason for this was because
according to Eurofetus criteria, 8 cm is not considered to be enough
to manifest clinical features of the recipient twin [9].
A limitation of our study is that the number of cases is small.
Precise prevalence of TTTS after 26 weeks is still unclear but a
number of cases are limited. In the 2 years of the study period, we
enrolled almost 200 cases of TTTS before 26 weeks treated with FLP
(unpublished data). This might imply the rarity of the cases.
In conclusion, our prospective pilot study shows that FLP could
be a therapeutic option for TTTS between 26weeks and 27weeks of
gestation.
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